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Abstract 
Background 
Aortic aneurysm repair is a resolutive and effective surgical operation, which can be associated with 
severe postoperative complications. Procalcitonin (PCT) in clinical practice could play a role in 
early diagnosis and monitoring of therapy for complications, especially infections, making for 
timely and more effective interventions. Our aim was to investigate whether PCT could be a 
predictive marker in early diagnosis of infectious complications after open abdominal aortic 
surgery. 
Methods 
Eighty-three consecutive patients who underwent elective open aortic repair at our institution were 
enrolled. Blood samples were taken before surgery, and each day over the 7-day postoperative 
period, and measurement of serum PCT, C-reactive protein (CRP), and leukocytes levels were 
carried out. Data regarding clinical progress, instrumental examinations, and blood chemistry were 
prospectively collected. 
Results 
Postoperative infectious complications occurred in 24 patients. Within 30 days, 1 death occurred. In 
the study sample, we found a significant difference in PCT curves of patients with and without 
infectious complications, especially on third postoperative day (POD; P = 0.004). On analysis of the 
area under the curve (AUC curve), PCT was shown to be a fair predictor in distinguishing cases 
with infectious complications (AUC, 0.765 on third POD; CI, 0.638–0.877). Conversely, other 
inflammatory markers commonly used (leucocytes and CRP) had similar trends in patients with and 
without postoperative infections. 
Conclusions 
On the basis of the results collected in this pilot study, despite some limitations, PCT could be 
considered a better marker of infectious complications after open abdominal aortic repair, when 
compared with other routinely used parameters. 
  
Main text 
Introduction 
Open aortic repair (OAR) is a high-risk surgical operation, due to the type of patient (usually 
elderly and frequently with associated comorbidities) and the invasiveness of the technique.
1,2 
Infections, especially pulmonary, are the most frequent type of complication, with important 
repercussions on patient morbidity, and mortality, prolonging hospitalization, and causing early 
readmission to hospital.
1,3
 For this reason, clinical, instrumental, or laboratory markers which would 
allow for an early diagnosis of this complications are needed, to reduce postoperative morbidities 
and their impact on patients' status. Procalcitonin (PCT) is a promising infection marker, whose 
serum levels can increase rapidly even several thousand times during microbial infections; 
furthermore, its increase can be correlated to the severity of the septic state, disease progress, and 
prognosis.
4-7
 Tissue trauma from a surgical operation and the resulting inflammatory response can, 
however, cause an increase in PCT. Moreover, those patients who develop postoperative 
complications have higher levels of PCT compared with those without complications. Postoperative 
induction of PCT largely depends on the type of surgery. During the first and second postoperative 
day (POD), PCT concentrations are more frequently elevated in patients after major surgery 
compared with patients undergoing minor operations.
8-22
 
Previous studies assessed PCT and its relationship with adverse postoperative events, mainly with 
regard to cardiac surgery,
8.22
 whereas very little evidence exists so far regarding infectious 
complications after aortic surgery.
23-26
 One of the most relevant aspects of PCT is its good 
specificity (SP), which has been recently demonstrated in the detection of postimplantation 
syndrome after endovascular repair.
25
 Our aim was to investigate the kinetics of PCT and determine 
its diagnostic and prognostic value after open abdominal aortic aneurysm (AAA) repair, comparing 
it with other indicators already used in clinical practice, that is C-reactive protein (CRP) and white 
blood cells (WBC). 
 
Materials and Methods 
Patients who underwent elective open aortic aneurysm repair at the Division of Vascular Surgery of 
the University of Turin during the period September 2012–December 2013 were consecutively 
enrolled. Inclusion criteria were: nonruptured AAAs larger than 5 cm or 4–5 cm rapidly enlarging 
and according to European Society for Vascular Surgery guidelines.
27
 Exclusion criteria were: 
aortic rupture, symptomatic AAAs, thoracoabdominal aneurysms, the need for suprarenal clamping, 
and endovascular repair. 
Each patient's medical history was recorded. In the preoperative phase, routine blood tests, 
electrocardiogram, chest X-ray, thoracic and abdominal computed tomography angiography, and 
cardiac evaluation were carried out in all patients. All patients signed the informed consent form for 
the surgical operation, anesthesia, data processing, and participation in the observational study. The 
protocol has been approved by the local ethical committee. A transperitoneal approach is our 
preferred access to the abdominal aorta (93% of patients), whereas a minority underwent a 
retroperitoneal approach. Antibiotic prophylaxis is usually stopped 24 hr after surgery; the Foley 
catheter is removed on third POD. Respiratory physiotherapy has been performed in selective 
patients (obese, patients with chronic obstructive pulmonary disease), usually starting on first POD. 
Blood samples were taken on the day before the operation and daily for 7 days after it (or until 
discharge if sooner) to measure the PCT, CRP, and WBC levels. PCT values after the first week 
were not taken into account. Plasma PCT was measured with an Elecsys automatic analyser 
(Hoffmann-La Roche Ltd., Basel, Switzerland) using an electrochemiluminescence immunoassay 
test. 
We considered infectious complications: pulmonary consolidation at X-ray with positive 
bronchoaspirate; positive uroculture (>100,000 colony forming units/mL) with urinary signs, or 
symptoms (dysuria, pollakiuria, cloudy and/or bloody urines); diarrhea with a positive coproculture; 
surgical wound signs of infections (purulent exudate). All infectious complications required 
prolonged antibiotic therapy. Renal function was monitored by measuring the serum creatinine 
values. A greater than 1.5-fold increase of creatinine level was considered significant for acute 
kidney injury.
28
 We considered all those infectious complications occurring within the 30th POD. 
All postoperative data were included in an Excel database. 
Statistical Analysis 
Continuous variables are reported as mean and standard deviation for normally distributed variables 
and as median and interquartile range for non-normal distributions, whereas categorical variables 
are reported as number of patients and percentages. Normality distribution has been tested with the 
Shapiro–Wilk normality test. Univariate analysis of the difference between groups (patients with 
versus without infectious complications) was performed with the Student's t-test or, when 
appropriate, by the nonparametric Mann–Whitney U test. Categorical data were compared with the 
chi-squared test. Statistical significance level was set at P ≤ 0.05. The receiving operating 
characteristic (ROC) curve and the value of the area under the curve (AUC) were calculated for the 
daily value of the different blood markers and used to analyze their accuracy as predictors of 
infectious complications. AUC values higher than 0.70 were considered as strong predictive ability. 
For the ROC curves with AUC higher than 0.70, sensitivity (SE), SP, positive likelihood ratio 
(LR+), and negative likelihood ratio (LR−) were calculated for different cutoff points. The results 
were analyzed using the StataMP11 statistical software (Stata Corp., College Station, TX, 2011). 
Results 
Eighty-three (80 men) patients were included in the study (Table I). Forty-five patients had no 
complications (54%). Within 30 days, 1 death occurred on 23rd POD due to septic shock after 
severe pneumonia. Complications were recorded in 38 patients (46%), 24 (29%) of whom were due 
to infections, whereas 17 patients (20%) had a deterioration of renal function, without need for 
dialysis. Infectious complications are presented in Table II. Noninfectious complications (n = 14) 
included: 8 acute intraoperative limb ischemia, 5 patients with temporary atrial fibrillation, and 1 
myocardial infarction. There was a significant difference in the occurrence of postoperative acute 
kidney injury between patients with and without infectious complications (13.6 vs. 37.5%, P = 
0.014). The main postoperative characteristics and procedures are presented in Table III. 
Pulmonary infections occurred in 16 patients: in 13 patients were clinically evident (coughing with 
purulent expectorate) associated with radiological signs of pneumonia, whereas in 3 patients 
positive bronchoaspirates without radiological signs were identified. In 3 patients, there was a 
urinary tract infection from bladder catheter, identified with a positive uroculture. There were 4 
cases of infections of the intestinal tract with diarrhea, diagnosed with positive coproculture, which 
resolved with antibiotic therapy. In 2 cases, we observed an infection of the surgical wound with 
purulent secretions, but no microbiological examination was carried out. Overall, there have been 
25 infectious complications, occurred in 24 patients because 1 patient developed both pulmonary 
and intestinal tract infection. Inflammatory markers increased as result of surgery in all patients. 
PCT showed an increase in POD 1 in all patients, with a subsequent decrease in patients without 
infectious complications, while patients with infections had a further increase in the following days, 
with a significant differences in POD 2 (P = 0.022), in POD 3 (P = 0.004), in POD 4 (P = 0.019), 
and in POD 5 (P = 0.011), whereas thereafter no significant differences were found between the 
groups. CRP showed a marked increase after surgery, with a peak in POD 3 and a subsequent 
decrease in both groups of patients, with no significant differences between patients with and 
without infections. Also WBC levels, although higher in patients with infections, showed a similar 
behavior between patients with and without infectious complications, except for a significant higher 
WBC level in patients with infections in POD 1 compared with those without infections (P = 
0.025). Blood markers levels trends in the first postoperative week are summarized in Table A.I and 
Figure 1. 
Thereafter, a ROC analysis of blood markers levels was performed. Based on the markers’ behavior 
(Fig. 1), the analysis was performed on POD 1-to-5 levels. PCT showed AUC higher than 0.7 thus 
proving to significantly differentiate patients with infections on POD 3 (cutoff 0.34 ng/mL, 
AUC = 0.765, SE = 85.7%, SP = 59%), on POD 4 (cutoff 0.46 ng/mL, AUC = 0.713, SE = 78.6%, 
SP = 68.4%), and on POD 5 (cutoff 0.29 ng/mL, AUC = 0.757, SE = 71.4%, SP = 80.9%). The 
AUC of CRP and WBC was lower than 0.70 on all POD (Table IV and Fig. 2). Thus, PCT proved 
to be the most accurate blood markers to early detect patients with ongoing or subsequent infectious 
complications, compared with CRP and WBC. However, the exact time of occurrence of an 
infectious complication is frequently hard to be identified, as it may take some time before clinical 
or laboratoristic signs become evident. Therefore, it is seldom possible to calculate the real time 
frame between PCT raise and the diagnosis of an infectious complication. PCT levels in day 3, that 
is the earlier time point with a significant AUC, were then evaluated for SE, SP at different cutoff 
point (Table V). 
 
Discussion 
Previous studies have investigated PCT levels after different types of surgery showing that peak 
level of PCT concentration, even in patients without signs of infections, depends on the type of 
operation—concentrations are more frequently elevated after major surgery—most of all cardiac 
procedures.
8,10
 This means that it is important to establish different cutoff values of PCT for each 
type of surgery. For e.g., Molter
10
 assessed that PCT concentrations higher than 0.2 ng/mL after 
minor aseptic surgery, 0.8 ng/mL after major abdominal surgery, 0.9 ng/mL after hepatic surgery, 
or 0.45 ng/mL after thoracic surgery may be predictive of infectious complications. OAR is a major 
abdominal operation, but unlike general surgery, it represents a ―clean‖ intervention, as respiratory, 
alimentary, and genitourinary tracts are not involved, thus infections are expected to be lower in this 
field. According to most of the aforementioned studies,
10, 11, 15, 19-21
 we focused our attention on the 
evaluation of only infectious complications. In our series, 29% of patients developed infectious 
complications. This is quite higher when compared with the data of Vogel (11%).
1
 However, these 
authors collected data from nationwide data sets, which are based on International Classification of 
Diseases-9 codes, thus they do not report which parameters were considered from any single center 
to identify an infectious complication. Nevertheless, in agreement with these authors, in the present 
study patients who experienced postoperative infectious events showed PCT curves with 
significantly higher peak values more often beginning on the third POD. Our ROC curve analysis of 
postoperative PCT values identified an AUC > 0.7 on third, fourth, and fifth POD, while other 
markers (CRP and WBC) did not reach significant AUC values. Thus, to identify a cutoff value, 
which could be a reliable alert of development of infection, we chose the third POD, which 
represents the earlier day of onset of a hypothetical infectious complication with a statistical 
significance (Table IV). According to our analysis (Table V), the best cutoff value of PCT on the 
third POD is 0.56 ng/mL, with a good (although not optimal) sensibility (71%), and SP (74%). This 
value is similar to thoracic surgery, as reported by Molter.
10
 Recommendations in complex vascular 
procedures, that is abdominal vessels reconstructions, suggest to stop antimicrobical prophylaxis 
24 hr after surgery.
29
 Our findings, whether confirmed by larger studies, could have a clinical 
impact on routine practice. In fact, according to our results, if an increasing trend of PCT values 
was detected on third POD, an infectious complication should be highly suspected and further 
examinations required to early start the proper antibiotic therapy. However, according to other 
authors,
23,24
 acute postoperative renal insufficiency could be a confounding factor in the evaluation 
of PCT for the diagnosis of infections. In fact, postoperative renal failure occurred almost 3 times 
more frequently in patients with infectious complications than those without infectious 
complications (37 vs. 13%). This may explain the correlation between postoperative renal and 
infectious adverse events. On the other hand, however, it is reasonable to suspect that patients with 
infectious complications, especially when these lead to septic shock, may also have a renal function 
worsening, as part of a general multiorgan failure The CRP can undergo nonspecific modifications 
mainly because of the mere tissue trauma of the surgical intervention itself. Values obtained from 
patients with or without infectious complications were similar and did not show significant 
differences in the statistical analysis. For this reason, CRP does not seem to have a predicting value 
for the early diagnosis of postoperative infectious complications. WBC count has a good capacity to 
distinguish patients with complications, but differently from PCT, the large variability in the 
kinetics of this parameter does not allow us to make a judgment on the progress of the pathologic 
condition. We only identify a statistical significant difference between the 2 groups on first POD, 
but later both groups had similar values. Our study has some limitations. The small sample size did 
not allow to reach a statistical significance at the multivariate analysis, as it did at the univariate 
analysis. Second, a comparison of PCT curves of patients with infectious complications and patients 
with other postoperative adverse events could have showed whether PCT levels would be higher in 
all postoperative complications, regardless of their etiology. Third, renal failure is an important 
confounding factor that may limit the predictive role of PCT in the early diagnosis of postoperative 
infections, also considering the fact that postoperative renal function deterioration is quite frequent 
after abdominal aortic surgery.
30
 Finally, physicians were not blinded to PCT values; therefore, they 
might have ordered more radiological and microbiological examinations, if PCT was seen to be 
high. New topics for future researches could be the interpretation of PCT values in relation to the 
deterioration of renal function, the comparison of PCT curves in patients with different types of 
postoperative complications (not only infections), and the role of PCT in guiding therapy to prevent 
postoperative complications in association with other markers. 
Conclusions 
On the basis of the results collected in this study, PCT could be considered as a valuable marker of 
infectious complications in the postoperative phase after open abdominal aortic repair. Despite its 
limitations, at the current time, PCT is maybe the best among the available markers of postoperative 
infectious complications. Therefore, the routine use of PCT could help physicians in identifying 
earlier those patients who have a greater risk of developing these potentially lethal complications to 
start specific preventive treatments. 
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Table I. Overall baseline characteristics of the 2 groups of comparison 
Variable categories 
Patients without infectious 
complications, n = 59 (71%) 
Patients with infectious 
complications, n = 24 (29%) 
P 
value 
 Male sex, n (%) 57 (97) 23 (96) 0.86 
Continuous variables 
 Age, mean ± standard 
deviation 
70.03 ± 7.22 71.96 ± 7.09 0.27 
 PCT before surgery, 
median (IQR) 
0.04 (0.03; 0.06) ng/mL 0.05 (0.04; 0.06) ng/mL 0.27 
 CRP before surgery, 
median (IQR) 
1.75 (0.70; 6.5) mg/L 2.80 (1.40; 8.5) mg/L 0.25 
 WBC before surgery, 
median (IQR) 
7.35 (6.38; 9.45) 10
9
/L 7.62 (6.81; 9.12) 10
9
/L 0.79 
IQR, interquartile range. 
  
Table II. Postoperative infectious complications 
Type of infectious complications Number of cases (total = 25) 
Pulmonary 16 
Urinary 3 
Gastrointestinal 4 
Surgical wound 2 
 
  
Table III. Postoperative details 
 
Patients without infectious 
complications, n = 59 (71%) 
Patients with infectious 
complications, n = 24 (29%) 
P 
value 
Variable categories 
 Deterioration of renal 
function, n (%) 
8 (14) 9 (37) 0.01 
 Postoperative period 
(<24 h), n (%)   
0.15 
 Ward 14 (24) 5 (21) 
 PACU 21 (36) 4 (17) 
 ICU 24 (41) 15 (62) 
Continuous variables 
 Creatinine peak/base 
ratio, median (IQR) 
1.15 (1.02; 1.43) 1.14 (1.02; 1.4) 0.12 
 Day of discharge, 
median (IQR), days 
6 (6; 7.75) 10 (7; 17.75) <0.001 
 Time in OT, median 
(IQR), hr 
6.00 (5.15; 6.5) 6.00 (6; 7) 0.13 
 Duration of operation, 
median (IQR), hr 
4.00 (3.25; 5) 4.50 (3.69; 5.63) 0.12 
 Duration of clamping, 
median (IQR), hr 
1.50 (1; 2) 1.58 (1.19; 2) 0.53 
 Hours of intubation, 
median (IQR), hr 
5.00 (4; 6.5) 5.50 (4.38; 12.5) 0.23 
PACU, postanesthesia care unit; ICU, intensive care unit; OT, operating theater; IQR, interquartile range. 
  
Fig. 1. Daily median levels of PCT (A), CRP (B), and WBC (C) in patients with and without 
infectious complications. *Indicates statistically significant differences. IQR, interquartile 
ranges. Blue lines, patients without infectious complications (IC); red lines, patients with IC. 
 
  
Table IV. Comparison of the accuracy of blood markers to detect infectious complications on 
POD 1-to-5 
 
AUC (95% CI) 
PCT POD1 0.617 (0.436–0.798) 
PCT POD2 0.690 (0.544–0.836) 
PCT POD3 0.765 (0.622–0.907) 
PCT POD4 0.713 (0.544–0.883) 
PCT POD5 0.757 (0.571–0.943) 
CRP POD1 0.607 (0.443–0.771) 
CRP POD2 0.615 (0.460–0.770) 
CRP POD3 0.474 (0.287–0.660) 
CRP POD4 0.527 (0.340–0.714) 
CRP POD5 0.641 (0.448–0.833) 
WBC POD1 0.659 (0.526–0.791) 
WBC POD2 0.617 (0.470–0.764) 
WBC POD3 0.602 (0.453–0.752) 
WBC POD4 0.599 (0.441–0.757) 
WBC POD5 0.622 (0.471–0.773) 
Bold indicates strong predictive values of PCT. 
  
Fig. 2. ROC curves comparison among PCT, CRP, and WBC levels on POD 3 (A), 4 (B), and 
5 (C). 
 
  
Table V. Comparison of the accuracy of different PCT cutoff points on POD 3 
Cutoff, ng/mL SE (%) SP (%) LR+ LR− 
0.20 93 46 1.72 0.15 
0.29 86 54 1.86 0.27 
0.34 86 59 2.09 0.24 
0.41 79 62 2.04 0.35 
0.48 71 72 2.53 0.40 
0.56 71 74 2.79 0.38 
0.60 57 77 2.48 0.56 
0.70 50 82 2.79 0.61 
0.98 43 85 2.79 0.68 
LR+, positive likelihood ratio; LR−, negative likelihood ratio. 
  
Appendix.  
Table A.I. Daily median levels of inflammatory markers 
 
All patients, 
n = 83 
Patients without infectious 
complications, n = 59 
Patients with infectious 
complications, n = 24 
P 
value
a
 
PCT, median (IQR) 
 Before 
surgery 
0.05 (0.04–
0.06) 
0.04 (0.03–0.06) 0.05 (0.04–0.06) 0.27 
 POD 0 
0.07 (0.06–
0.11) 
0.08 (0.06–0.13) 0.07 (0.06–0.10) 0.60 
 POD 1 
0.52 (0.23–
1.16) 
0.43 (0.23–1.04) 0.68 (0.51–1.24) 0.23 
 POD 2 
0.42 (0.22–
1.08) 
0.30 (0.19–1.02) 0.92 (0.46–2.26) 0.02 
 POD 3 
0.35 (0.18–
0.70) 
0.22 (0.17–0.54) 0.67 (0.46–1.69) 0.004 
 POD 4 
0.24 (0.16–
0.78) 
0.22 (0.15–0.54) 0.66 (0.47–1.42) 0.02 
 POD 5 
0.17 (0.12–
0.37) 
0.15 (0.12–0.23) 0.37 (0.20–0.77) 0.01 
 POD 6 
0.25 (0.14–
0.40) 
0.24 (0.15–0.41) 0.27 (0.16–0.38) 0.95 
 POD 7 
0.23 (0.11–
0.73) 
0.12 (0.08–0.43) 0.28 (0.13–1.21) 0.35 
CRP, median (IQR) 
 Before 
surgery 
1.80 (1.10–
6.60) 
1.75 (0.80–6.03) 2.80 (1.45–8.05) 0.25 
 POD 0 
6.15 (2.83–
15.13) 
6.55 (2.88–13.38) 5.50 (2.28–20.70) 0.83 
 POD 1 
78.90 (53.30–
112.10) 
64.00 (52.50–105.50) 95.65 (72.88–115.68) 0.22 
 All patients, 
n = 83 
Patients without infectious 
complications, n = 59 
Patients with infectious 
complications, n = 24 
P 
value
a
 
 POD 2 
174.75 
(107.40–
218.08) 
171.20 (101.70–206.20) 182.30 (145.60–221.70) 0.18 
 POD 3 
205.3 (149.6–
259.8) 
200.4 (150.3–259.8) 208.6 (128.2–261.2) 0.76 
 POD 4 
132.50 (90.35–
206.83) 
134.10 (91.05–204.48) 131.40 (96.33–203.90) 0.77 
 POD 5 
83.40 (59.13–
138.68) 
77.30 (50.15–127.75) 119.80 (72.90–154.00) 0.15 
 POD 6 
57.85 (41.38–
100.25) 
76.35 (41.33–96.65) 48.70 (44.45–104.48) 1 
 POD 7 
80.45 (41.35–
135.20) 
43.10 (28.50–102.80) 83.90 (42.20–126.10) 0.52 
WBC, median (IQR) 
 Before 
surgery 
7.36 (6.44–
9.31) 
7.35 (6.38–9.42) 7.62 (6.89–8.84) 0.79 
 POD 0 
12.02 (10.41–
15.34) 
11.69 (10.00–14.77) 12.47 (11.50–19.23) 0.15 
 POD 1 
11.29 (9.57–
13.76) 
10.67 (9.51–13.40) 13.08 (11.07–15.13) 0.02 
 POD 2 
11.35 (9.34–
14.38) 
11.14 (9.23–13.54) 13.12 (10.77–14.68) 0.10 
 POD 3 
10.70 (9.03–
12.16) 
10.34 (8.91–11.93) 11.34 (9.91–13.19) 0.16 
 POD 4 
8.60 (6.92–
10.90) 
8.27 (6.89–10.18) 9.39 (7.34–11.73) 0.18 
 POD 5 
8.22 (6.23–
10.28) 
8.08 (6.08–9.92) 9.05 (6.98–11.08) 0.11 
 All patients, 
n = 83 
Patients without infectious 
complications, n = 59 
Patients with infectious 
complications, n = 24 
P 
value
a
 
 POD 6 
9.55 (7.31–
10.80) 
8.78 (6.94–10.09) 10.34 (8.88–12.03) 0.07 
 POD 7 
9.75 (8.10–
12.18) 
9.47 (7.61–12.02) 10.38 (8.33–11.91) 0.50 
Bold indicates strong predictive values of PCT. 
a Mann–Whitney test. 
 
